The Natural History of Geographic Atrophy Progression (GAP) Study

Alcon Research1,000 enrolled

Overview

The objective of the 18-month trial is to evaluate the natural history of geographic atrophy by assessing the rate of progression of the geographic atrophic lesion over time.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Eligibility

Sex: ALLMin age: 55 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of geographic atrophy secondary to age-related macular degeneration with no CNV lesion. Exclusion Criteria: * Age related

Locations (1)

Houston

Houston, Texas, United States

Outcomes

Primary Outcomes

GA progression rate using fundus autofluorescence

Time frame: From baseline

Secondary Outcomes

GA progression rate using fundus photography

Time frame: From baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.